These results suggest that co‐deletion of BRCA2 and RB1, most of which are attributed to somatic heterozygous deletions, is a frequent phenomenon in localized PC and that patients with BRCA2 deletions frequently have poorer prognoses from localized PC. This evidence concerns the gene BRCA2 and pachyonychia congenita.